Author

William Sharis

Observed name: W. Sharis

Institution: Midwest Cardiovascular Research Foundation

Observed institution: Midwest Cardiovascular Research Foundation

ORCID: 0009-0004-1507-6646

Observed ORCID: 0009-0004-1507-6646

OpenAlex ID: A5094001436

Predictors of Patency Following Infrainguinal Arterial Interventions Under Intravascular Ultrasound Guidance: Analysis from the iDissection Studies

2025 · Nicolas Shammas, Gail Shammas, et al. · Vascular Health and Risk Management · 2

Mechanical Thrombectomy and Catheter-Directed Lysis in Treating Intermediate-Risk Pulmonary Embolization: 30-Day Outcome

2025 · Nicolas W. Shammas, William Sharis, et al. · International Journal of Angiology · 2

Predictors of Use of Pharmacomechanical Therapies versus Standard Therapy in Intermediate-Risk Pulmonary Embolism: A Retrospective Study from Two Medical Centers

2026 · Nicolas W. Shammas, William Sharis, et al. · International Journal of Angiology

300.17 Mechanical Thrombectomy or Catheter-Directed Lysis Versus Heparin in Treating Intermediate-Risk Pulmonary Embolism: 30-Day Outcomes

2026 · Nicolas W. Shammas, William Sharis, et al. · JACC: Cardiovascular Interventions

200.16 Patency and Target Lesion Revascularization in Patients Undergoing Femoropopliteal Versus Infrapopliteal Interventions Under Intravascular Ultrasound Guidance

2025 · Nicolas W. Shammas, Gail Shammas, et al. · JACC: Cardiovascular Interventions

200.12 Predictors of Patency and Target Lesion Revascularization Following Infrainguinal Arterial Interventions Under Intravascular Ultrasound Guidance: Analysis From the iDissection Studies

2025 · Nicolas W. Shammas, Gail Shammas, et al. · JACC: Cardiovascular Interventions

TCT-729 Thirty-Day Outcome of Pharmacomechanical Devices in Treating Intermediate-Risk Pulmonary Embolization: Real-World Data From Two Medical Centers

2024 · Nicolas Shammas, William Sharis, et al. · Journal of the American College of Cardiology

Acute Procedural Results and Major Adverse Events Among Various Pharmacomechanical Devices in Treating Intermediate-Risk Pulmonary Embolization: Real-World Data From Two Medical Centers

2024 · N.W. Shammas, W. Sharis, et al. · Cardiovascular revascularization medicine

300.21 Acute Procedural Results and Major Adverse Events Among Various Pharmacomechanical Devices in Treating Intermediate-Risk Pulmonary Embolization: Real-World Data From Two Medical Centers

2024 · N.W. Shammas, W. Sharis, et al. · JACC: Cardiovascular Interventions

Works count: 9

Citation count: 4

H-index: 2

I10-index: